These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 3471089
61. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital. Limpanasithikul W, Wangsaturaka D, Nantawan P, Itthipanichapong C, Thamaree S, Wittayalertpanya S, Ketcharoen A, Taworn N, Kemsri W, Kusolsomboon T, Tangphao O. J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432 [Abstract] [Full Text] [Related]
62. Promoting the cost-effective utilization of cefoxitin with a drug use education program. Wein PJ, Hoffman RP. Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016 [Abstract] [Full Text] [Related]
63. Clinical appropriateness, therapeutic equivalence, and cost of conversion of H2 antagonist therapy. Kitrenos JG, Brown DR, Letting DJ, Rotella DL. Hosp Formul; 1993 Jan; 28(1):86-8, 91, 95-6. PubMed ID: 10123271 [Abstract] [Full Text] [Related]
64. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary. Cramer R, Wright C. Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858 [Abstract] [Full Text] [Related]
65. The goals and functions of a P & T committee. Sudds TW, Williams RR. Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572 [Abstract] [Full Text] [Related]
66. Mission, role, and functions of the P & T Committee. Bell JE, Evans PJ, Standish RC. Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202 [Abstract] [Full Text] [Related]
67. Assuring rational antibiotic use: the impact of a joint microbiology-pharmacy surveillance program. Plumridge RJ, McGechie DB. Aust Health Rev; 1984 Jun; 7(4):269-77. PubMed ID: 10269945 [Abstract] [Full Text] [Related]
68. 1988 Joint Commission survey in a community hospital. Guharoy S, Barajas M, McGalliard J, Aguer T. Hosp Pharm; 1989 Apr; 24(4):287-9. PubMed ID: 10293284 [Abstract] [Full Text] [Related]
69. Antimicrobial formulary management: meeting the challenge in the community hospital. Rush DR. Pharmacotherapy; 1991 Apr; 11(1 ( Pt 2)):19S-26S. PubMed ID: 2011569 [Abstract] [Full Text] [Related]
70. P & T Committee interview: Promoting rational drug use. Hunt TK, Herfindal ET. Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839 [Abstract] [Full Text] [Related]
71. Criteria-based DUE aids in selection of preferred agent. Drea EJ. Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562 [Abstract] [Full Text] [Related]
72. P & T Committee formulary requests: criteria for admission. Weintraub M, Guttmacher L. Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315 [Abstract] [Full Text] [Related]
73. Communicating P & T guidelines: how one committee meets the challenge. Dreyfus R, Bender F. Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681 [Abstract] [Full Text] [Related]
76. The formulary decision-making process in a US academic medical centre. Nash DB, Catalano ML, Wordell CJ. Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985 [Abstract] [Full Text] [Related]
77. Improvement in antibiotic use secondary to a small hospital antibiotic review. Strahl DA, Wightkin WT. Hosp Formul; 1985 Mar; 20(3):310-2. PubMed ID: 10270306 [Abstract] [Full Text] [Related]